Approval · Notice of Compliance 10150 · 2009
COPAXONE: Notice of Compliance 10150
Issued April 15, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10150
- Date
- April 15, 2009
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Treatment of patients with Clinically Isolated Syndrome (CIS), suggestive of Multiple Sclerosis
- Therapeutic class
- Immunomodulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COPAXONE | Not yet assigned | — |
Medicinal ingredients
- GLATIRAMER ACETATE 20 MG per ML
- GLATIRAMER ACETATE 20 MG per VIAL